Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Automatic Prediction of Malignant Brain Edema After Middle Cerebral Artery Ischemic -Stroke

NCT04057690 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT04057690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04057690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Automatic Prediction of Malignant Brain Edema After Middle Cerebral Artery Ischemic -Stroke
Lead sponsor
University Hospital Tuebingen
Phase
Observational
Overall status
Active, not recruiting
Start date
April 1, 2019
Completion date
December 31, 2025
Enrollment
1,687 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

brain edema, stroke, acute